Ovid Therapeutics (OVID)
2.40
+0.02 (0.84%)
Upcoming Events
Latest Headlines
B.Riley on Ovid Therapeutics Inc (OVID): 'one of our top picks from last week's B. Riley MMV Summit'
July 21, 2026 5:16 AM - StreetInsider
Form 4 Ovid Therapeutics Inc. For: Jul 06 Filed by: Carter Charles Ross
July 8, 2026 4:32 PM - SEC Filing
Form 3 Ovid Therapeutics Inc. For: Jul 06 Filed by: Carter Charles Ross
July 8, 2026 4:28 PM - SEC Filing
Form SCHEDULE 13G/A Ovid Therapeutics Inc. Filed by: FEDERATED HERMES, INC.
July 8, 2026 7:55 AM - SEC Filing
Form 8-K Ovid Therapeutics Inc. For: Jul 05
July 8, 2026 7:04 AM - SEC Filing
Ovid Therapeutics names new CFO and CBO in leadership reshuffle
July 8, 2026 7:02 AM - StreetInsider
Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development
July 8, 2026 7:00 AM - StreetInsider
Form 4 Ovid Therapeutics Inc. For: Jun 15 Filed by: Greka Anna
June 17, 2026 4:22 PM - SEC Filing
Form 3 Ovid Therapeutics Inc. For: Jun 15 Filed by: Greka Anna
June 17, 2026 4:20 PM - SEC Filing
Form 8-K Ovid Therapeutics Inc. For: Jun 11
June 11, 2026 9:03 AM - SEC Filing
Ovid Therapeutics to Participate in Upcoming Investor Conferences
June 4, 2026 7:00 AM - StreetInsider
Form 8-K Ovid Therapeutics Inc. For: May 29
June 3, 2026 7:03 AM - SEC Filing
Ovid Therapeutics names Anna Greka to board of directors
June 3, 2026 7:00 AM - StreetInsider
Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors
June 3, 2026 7:00 AM - StreetInsider
Form SCHEDULE 13G/A Ovid Therapeutics Inc. Filed by: Point72 Asset Management, L.P.
May 15, 2026 4:30 PM - SEC Filing
Form SCHEDULE 13G Ovid Therapeutics Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC
May 15, 2026 11:58 AM - SEC Filing
Form SCHEDULE 13G Ovid Therapeutics Inc. Filed by: Sirenia Capital Management LP
May 15, 2026 8:04 AM - SEC Filing
Form SCHEDULE 13G Ovid Therapeutics Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 6:36 AM - SEC Filing
Form SCHEDULE 13G/A Ovid Therapeutics Inc. Filed by: LEVIN JEREMY M
May 14, 2026 4:29 PM - SEC Filing
Form SCHEDULE 13G/A Ovid Therapeutics Inc. Filed by: Affinity Asset Advisors, LLC
May 14, 2026 4:19 PM - SEC Filing
B.Riley Reiterates Buy Rating on Ovid Therapeutics Inc (OVID)
May 13, 2026 4:16 AM - StreetInsider
Ovid Therapeutics Inc. (OVID) Reports In-Line Q1 EPS
May 12, 2026 7:26 AM - StreetInsider
Form 10-Q Ovid Therapeutics Inc. For: Mar 31
May 12, 2026 7:07 AM - SEC Filing
Form 8-K Ovid Therapeutics Inc. For: May 12
May 12, 2026 7:04 AM - SEC Filing
Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results
May 12, 2026 7:01 AM - Globe NewsWire
Form ARS Ovid Therapeutics Inc. For: Dec 31
April 27, 2026 5:13 PM - SEC Filing
Form DEFA14A Ovid Therapeutics Inc.
April 27, 2026 5:12 PM - SEC Filing
Form DEF 14A Ovid Therapeutics Inc. For: Dec 31
April 27, 2026 5:11 PM - SEC Filing
Form 424B3 Ovid Therapeutics Inc.
April 27, 2026 5:01 PM - SEC Filing
Form EFFECT Ovid Therapeutics Inc.
April 27, 2026 6:04 AM - SEC Filing
Full Article List
